0
$0.00
Mini Cart
  • Empty cart

    No products in the cart.

References For Vitex Agnus castus – Kaf.m product

References For Vitex Agnus castus – Kaf.m product

– Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol Clin Exp 2003, 18: 191-195.

– Aviva Romm, MD. Botanical Medicine for Women’s Health. Churchill Livingstone, 2009.

– Berger D, Schaffner W, Schrader E, Meier B, Brattström A. Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS). Arch Gynecol Obstet 2000, 264: 150-153.

– Blaschek W, Ebel S, Hackenthal E, et al. HagerROM 2002: Hagers Handbuch der Drogen und Arzneistoffe. Heidelberg: Springer; 2002.

– Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council; 1998.

– Brinker F. “Botanical Medicine Research Summaries,” from Eclectic Dispensatory of Botanical Therapeutics, vol. II. Eclectic Medical Pub., Sandy, Ore., 1995.

– Brinker F. Herb Contraindications and Drug Interactions, 4th ed. Sandy (OR): Eclectic Medical Publications; 2010.

– Brown D. Vitex agnus castus Clinical monograph. Quart. Rev. Nat. Med., pp. 111-121,Summer, 1994.

– Christie S, Walker AF. Vitex agnus-castus L.: (1) A review of its traditional and modern therapeutic use. (2) Current use from a survey of practitioners. Eur J Herbal Med. 1997;3(3):29–45.

– European Medicines Agency. Assessment report on Vitex agnus-castus L., fructus. Committee on Herbal Medicinal Products (HMPC). 25 November 2010.

– European Pharmacopoeia, Ph. Eur. 6th ed. Agnus Castus fruit. Council of Europe. 1/2008: 2147.

– Farnsworth NR, Bingel AS, Cordell GA, et al. Potential value of plants as sources of new antifertility agents I. J. Pharm. Sci., 64:535-598, 1975.

– Gallagher J, Lynch FW, Barragry J. Eur J Obstet Gynecol Reprod Biol. 2008;137(2):257– 258.

– Ganapaty S, Vidyadhar KN. Phytoconstituents and biological activities of Vitex – a review. J Nat Remedies 2005, 5(2): 75-95.

– Gruenwald J, Brendler T, Jaenicke C (eds.). PDR for Herbal Medicines. Medical Economics Co., Inc., Montvale, NJ, 1998.

– Hajdu Z, Hohmann J, Forgo P, Martinek T, Dervarics M, Zupko I, Falkay G, Cossuta D, Mathe I. Diterpenoids and flavonoids from the fruits of Vitex agnus-castus and antioxidant activity of the fruit extracts and their constituents. Phytotherpay Research 2007, 21: 391-394.

– He Z, Chen R, Zhou Y, Geng L, Zhang Z, Chen S, Yao Y, Lu J, Lin S. Treatment of premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multi-center placebo controlled study in China. Maturitas 2009, 63: 99-103.

– Ho SH, Singh M, Holloway AC, Crankshaw DJ. The effects of commercial preparations of herbal supplements commonly used by women on the biotransformation of fluorogenic substrates by human cytochromes P450. Phytother Res. 2011 Jul;25(7):983-9.

– Kilicdag EB, Tarim E, Bagis T, et al. Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia. Int. J. Gyn. Obs., 85:292-293, 2004.

– Lal R, Sankaranarayanan A, Mathur VS, et al. Bull Postgrad Inst Med Educ Res Chandigarh. 1985;19(2):44–47.

– Liu J, Burdette JE, Sun Y, Deng S, Schlecht SM, Zheng W, Nikolic D, Mahady G, van Breemen RB, Fong HHS, Pezzuto JM, Bolton JL, Farnsworth NR. Isolation of linoleic acid as an estrogenic compound from the fruits of Vitex agnus-castus L. (chaste-berry). Phytomedicine 2004, 11(1): 18-23.

– Lucks BC. Vitex agnus castus essential oil and menopausal balance: a research update [Complementary Therapies in Nursing and Midwifery 8 2003, 148-154.

– Mills S, Bone K. Principles and practice of Phytotherapy. Modern Herbal Medicine, 2ed. Churchill Livingstone, 2013.

– Ohyama K, Akaike T, Hirobe C, Yamakawa T. Cytotoxicity and apoptotic inducibility of Vitex agnus-castus fruit extract in cultured human normal and cancer cells and effect on growth. Biol Pharm Bull 2003, 26(1): 10-18.

– Peter Holmes. The Energetics of Western Herbs, Vol. 1, 4th Ed. Snow Lotus Press, 2007.

– Priplepskaya VN, Ledina AV, Tagiyeva AV, Revazova FS. Vitex agnus castus: Successful treatment of moderate to severe premenstrual syndrome. Maturitas 2006, 55: 55-63.

– Schellenberg R, Zimmermann C, Drewe J, Hoexter G, Zahner C. Dose-dependent efficacy of the Vitex agnus castus extract Ze 440 in patients suffering from premenstrual syndrome. Phytomedicine. 2012 Nov 15;19(14):1325-31.

– Tamagno G, Burlau MC, Daly AF, Beckers A. Vitex agnus castus might enrich the pharmacological armamenatarium for medical treatment of prolactinoma. European Journal of Obstetrics & Gynecology and Reproductive Biology 2007, 135: 139-140.

– Upton R, Petrone C, Graff A, eds. Chaste Tree Fruit: Vitex agnus-castus, American Herbal Pharmacopoeia and Therapeutic Compendium. Santa Cruz, CA: American Herbal Pharmacopoeia; 2001.

– Van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med. 2013May;79(7):562-75.

– Winterhoff H. Abstracts of papers of the American Chemical Society.1996;212 (1–2):AGFD 105.

– Wuttke W, Jarry H, Christoffel V, et al. Chaste tree (Vitex agnus-castus) – pharmacology and clinical indications. Phytomed., 10:348-357, 2003.

– Zamani M, Neghab N, Torabian S. Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome. Acta Med Iran. 2012;50(2):101-6.

– Zoë Gardner, Michael McGuffin. American Herbal Products Association’s Botanical Safety Handbook, Second Edition. CRC Press, 2013.

Leave us a comment

Cart Item Removed. Undo
  • No products in the cart.